The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dolmatil 200mg Tablets

200 milligram(s) Tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/147/001

Main Information

Trade NameDolmatil 200mg Tablets
Active SubstancesSulpiride
Strength200 milligram(s)
Dosage FormTablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/147/001

Group Information

ATC CodeN05AL Benzamides
N05AL01 sulpiride

Status

Authorised/WithdrawnAuthorised
Licence Issued08/04/1987
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back